Best Abstracts: Coronary | Antiplatelet Therapy & Chronic Total Occlusion

Moderator(s)

• 

  Kazuhiro Dan, MD, PhD, FACC

  Associate Director of Cardiovascular Medicine, Interventional Cardiologist
  Ichinomiya Nishi Hospital
  Ichinomiya, Aichi, Japan

  No relationships to disclose
• 

  Nauman Khalid, MD

  Interventional Cardiologist
  St. Francis Medical Center
  Monroe, Louisiana, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 11:00 AM – 11:08 AM ET

  Risk Of Bleeding Among Cangrelor-treated Patients Administered Upstream P2y12 Inhibitor Therapy
  

  Speaker: Jennifer Rymer, MD – Duke
• 11:08 AM – 11:12 AM ET

  Panel Discussion
• 11:12 AM – 11:20 AM ET

  A 30-day Pooled Analysis Of Acetyl Salicylic Elimination Trials (aset) In Brazil And Japan: Synergy Stent With Prasugrel Monotherapy Without Aspirin
  

  Speaker: Yoshinobu Onuma, MD, PhD (he/him/his) – National University of Ireland, Galway
• 11:20 AM – 11:24 AM ET

  Panel Discussion
• 11:24 AM – 11:32 AM ET

  Micrornas As Novel Biomarkers To Guide Dapt After Pci - Preliminary Assessment
  

  Speaker: Eric Rytkin, MD, PhD – Northwestern University
• 11:32 AM – 11:36 AM ET

  Panel Discussion
• 11:36 AM – 11:44 AM ET

  Temporal Evolution Of Percutaneous Recanalisation For Coronary Chronic Total Occlusions: An Italian Multicenter Experience
  

  Speaker: Niccolò Ciardetti, MD (he/him/his) – Careggi University Hospital
• 11:44 AM – 11:48 AM ET

  Panel Discussion
• 11:48 AM – 11:56 AM ET

  The Importance Of Intravascular Ultrasound And Intravascular Lithotripsy For Complex Coronary Chronic Total Occlusion Recanalisation: An Italian Multicenter Experience
  

  Speaker: Niccolò Ciardetti, MD (he/him/his) – Careggi University Hospital
• 11:56 AM – 12:00 PM ET

  Panel Discussion
• 12:00 PM ET

  Adjourn